Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing

OBJECTIVES: To test the feasibility of a randomised controlled trial (RCT) of aspirin and/or vitamin D3 in active surveillance (AS) low/favourable intermediate risk prostate cancer (PCa) patients with Prolaris® testing. PATIENTS AND METHODS: Newly‐diagnosed low/favourable intermediate risk PCa patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinneen, Eoin, Shaw, Gregory L., Kealy, Roseann, Alexandris, Panos, Finnegan, Kier, Chu, Kimberley, Haidar, Nadia, Santos‐Vidal, Sara, Kudahetti, Sakunthala, Moore, Caroline M., Grey, Alistair D. R., Berney, Daniel M., Sahdev, Anju, Cathcart, Paul J., Oliver, R. Timothy D., Rajan, Prabhakar, Cuzick, Jack, Madaan, Sanjeev, Pati, Jhumur, Chowdhury, Abdul M., Birch, Brian R. P., Dudderidge, Timothy J., Jefferson, Kieran P., Kynaston, Howard G., Green, James S. A., Powles, Thomas, Kemp, Victoria, Chu, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
To the Clinic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579886/
https://www.ncbi.nlm.nih.gov/pubmed/36267207
http://dx.doi.org/10.1002/bco2.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579886/
https://www.ncbi.nlm.nih.gov/pubmed/36267207
http://dx.doi.org/10.1002/bco2.169

Ejemplares similares